These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer. Mystakidou K, Befon S, Liossi C, Vlachos L. Cancer; 1998 Sep 15; 83(6):1214-23. PubMed ID: 9740088 [Abstract] [Full Text] [Related]
29. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting. Herrstedt J. Expert Opin Drug Saf; 2004 May 15; 3(3):231-48. PubMed ID: 15155151 [Abstract] [Full Text] [Related]
33. Advances in the management of nausea and vomiting. Hogan CM. Nurs Clin North Am; 1990 Jun 15; 25(2):475-97. PubMed ID: 2186393 [Abstract] [Full Text] [Related]
34. Managing bowel elimination problems in patients with cancer. Bisanz A. Oncol Nurs Forum; 1997 May 15; 24(4):679-86; quiz 687-8. PubMed ID: 9159783 [Abstract] [Full Text] [Related]
38. [Nausea and vomiting in cancer patients]. Lévy E, Scotté F, Médioni J, Oudard S. Rev Prat; 2006 Nov 30; 56(18):2015-9. PubMed ID: 17274504 [Abstract] [Full Text] [Related]
40. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide. Shih V, Wan HS, Chan A. Ann Pharmacother; 2009 Mar 30; 43(3):444-52. PubMed ID: 19193584 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]